Manhattan Scientifics Inc financial data

Symbol
MHTX on OTC
Location
244 Fifth Avenue, Suite 2341, New York, NY
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3 % -68.8%
Debt-to-equity -72.6 % +21.4%
Return On Equity 34.9 % -41.8%
Return On Assets -463 % -279%
Operating Margin -7.93K % -379%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 559M shares 0%
Common Stock, Shares, Outstanding 559M shares 0%
Entity Public Float 2.6M USD -45%
Common Stock, Value, Issued 559K USD 0%
Weighted Average Number of Shares Outstanding, Basic 559M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 559M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 10K USD -9.09%
General and Administrative Expense 673K USD -5.48%
Operating Income (Loss) -683K USD +4.34%
Nonoperating Income (Expense) -2.05M USD +30.5%
Net Income (Loss) Attributable to Parent -1.06M USD +5.38%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52K USD -86.5%
Assets, Current 45K USD -26.2%
Property, Plant and Equipment, Net 0 USD -100%
Assets 74K USD -87%
Accrued Liabilities, Current 2.18M USD +32.1%
Liabilities, Current 2.42M USD +30.2%
Liabilities 2.42M USD +30.2%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 1.06M USD 0%
Common Stocks, Including Additional Paid in Capital 1.06M USD
Retained Earnings (Accumulated Deficit) -73M USD -1.47%
Stockholders' Equity Attributable to Parent -3.4M USD -45.1%
Liabilities and Equity 74K USD -87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42K USD +44%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 26K USD
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 559M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -111K USD -12.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38K USD -26.9%
Deferred Tax Assets, Operating Loss Carryforwards 13.7M USD +1.81%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 69M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%